Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03091452

CArdioSurgEry Atrial Fibrillation Register

CASE AF aims to describe the reality of medical care of patients in whom atrial fibrillation is treated by cardiac surgical ablation.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Klinikum Bogenhausen, München, Bavaria, Germany

Loading trial locations.

About this study

CASE AF aims to describe the reality of medical care of patients in whom atrial fibrillation is treated by cardiac surgical ablation. In particular, the following questions should be answered:

  • Indication: Which are the different indications for cardiac surgical ablation in patients with atrial fibrillation?
  • How often and in which patients the different concepts of surgery and ablation procedures are used? At the same time, how often an intervention at the left atrial appendage is carried out?
  • Safety: How secure is the cardiac surgical ablation of atrial fibrillation (periprocedural, during hospital stay and during the long-term follow up)?
  • Effectiveness: How effectively is the cardiac surgical ablation of atrial fibrillation (procedural success)? How often are AF recurrences in the long-term follow up?
  • What is the concommitant medical treatment after surgical ablation?

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Atrial fibrilation
  • Treated by cardiac surgical ablation

Exclusion criteria

  • Patient denies participation

Treatment and study plan

Primary outcomes

  1. Number of major bleeding events

    Time frame: 12 months

    Documentation of procedural results and clinical short-and long-term results of the documented therapies

Secondary outcomes

  1. Number of major adverse cardiac events

    Time frame: 12 months

    Documentation of procedural results and clinical short-and long-term results of the documented therapies

  2. Complications during hospital stay

    Time frame: 12 months

    Documentation of hospital mortality, nonfatal major complications

Study contacts

Contact information is provided by the study sponsor or research team.

Belgin Özdemir

CONTACT

[email protected]

00496215032888

Sponsors and collaborators

Lead sponsor

Stiftung Institut fuer Herzinfarktforschung

Other

Registry information

Official study title

CArdioSurgEry Atrial Fibrillation Register - CASE-AF Register

Acronym: CASE-AF

Important dates

Study start
2017
Primary completion
2028
Study completion
2029
First posted
Mar 27, 2017
Registry last updated
Dec 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.